Literature DB >> 24460275

Effect of diallyl trisulfide on human ovarian cancer SKOV- 3/DDP cell apoptosis.

Hui-Fang Wan1, Le-Han Yu, Jin-Lan Wu, Shuo Tu, Wie-Feng Zhu, Xia-Li Zhang, Fu-Sheng Wan.   

Abstract

AIM: To investigate the effects of diallyl trisulfide (DT) on apoptosis of cisplatin (DDP)-resistant human epithelial ovarian cancer SKOV-3 cells (SKOV-3/DDP), and the role of p53 upregulated modulator of apoptosis (PUMA).
METHODS: SKOV-3/DDP cells were randomly divided into control, DT, DPP and DPP+DT groups, which were treated with DT or combined DT and DDP. All cells were incubated for 48 h. and apoptosis rates were assessed by flow cytometry. mRNA and protein expression of PUMA, Bax and Bcl-2 was determined by RT-PCR and Western blot assays, respectively.
RESULTS: Compared with control group, the apoptosis rates of SKOV-3/DDP cells in DT groups were obviously increased, with dose-dependence (P < 0.05), the mRNA and protein expressions of PUMA, Bax also being up-regulated (P < 0.05), while those of Bcl-2 were down-regulated (P < 0.05). Compared with DT groups, the apoptosis rate in the DDP+DT group was significantly increased (P < 0.05). After knockdown of PUMA with specific siRNA, the apoptosis rate of SKOV-3/DDP cells was obviously decreased (P < 0.05).
CONCLUSION: DT can promote the apoptosis of SKOV-3/DDP cells with PUMA playing a critical role.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24460275     DOI: 10.7314/apjcp.2013.14.12.7197

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

Review 1.  Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment.

Authors:  Michael T Puccinelli; Silvia D Stan
Journal:  Int J Mol Sci       Date:  2017-07-28       Impact factor: 5.923

2.  A possible mechanism of inhibition of U87MG and SH-SY5Y cancer cell proliferation by diallyl trisulfide and other aspects of its activity.

Authors:  Halina Jurkowska; Maria Wróbel; Marta Kaczor-Kamińska; Ewa Jasek-Gajda
Journal:  Amino Acids       Date:  2017-08-29       Impact factor: 3.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.